Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
CUPR · SEC Filings
website
10
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primaril...
Price
1.85
Market Cap
12.96 M
Float
5.24 M
Country
SG
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CUPR
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
CUPR · SEC Filings
5.24 M
Float
1.85
Price
12.96 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
20-F/A
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Jul 1, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 27, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 14, 2025
NT 20-F
Form NT 20-F - Notification of inability to timely file Form 20-F
Apr 17, 2025
News
TYPE
HEADLINE
FILED AT
6-K
Shareholders Approve Tenfold Increase in Authorized Share Capital, Restated Articles, and Potential Meeting Adjournment Measures
Oct 20, 2026
6-K
Cuprina to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
Oct 2, 2026
6-K
Cuprina Holdings Closes Underwriter’s Over-Allotment Option, Bringing Total Public Offering Gross Proceeds to Approximately $5.72 Million
Sep 29, 2026
6-K
Cuprina Holdings Announces Extraordinary General Meeting of Shareholders to Vote on Share Capital Increase and Articles of Association Amendment
Sep 18, 2026
6-K
Cuprina Holdings (Cayman) Limited Announces Pricing of $4.97 million Public Offering
Sep 17, 2026
6-K
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots
Jun 15, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
Form 424B4 - Prospectus [Rule 424(b)(4)]
Sep 16, 2026
424B4
OFFERING (Initial Public Offering) - R. F. Lafferty & Co., Inc. | Shares amount: 3,000,000 | Share price: $4 | Warrants exercise price: $5 | Offering amount: $12,000,000
Apr 10, 2025
Registrations
TYPE
HEADLINE
FILED AT
F-1/A
OFFERING - Firm Commitment
Sep 11, 2026
F-1
OFFERING (Firm Commitment) - R. F. Lafferty & Co., Inc.
Jul 7, 2026
DRS
Form DRS - Draft Registration Statement
Jun 5, 2026
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
Apr 9, 2025
F-1/A
SHARE RESALE REGISTRATION
Feb 14, 2025
F-1/A
SHARE RESALE REGISTRATION | Shares amount: 3,750,000 | Share price: $4.25 | Offering amount: $15,937,500
Feb 5, 2025
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
JANE STREET GROUP, LLC (Filed by)
Nov 6, 2026
SCHEDULE 13G
JANE STREET GROUP, LLC (Filed by)
Jul 28, 2026
3
CHAN Tat Jing (Reporting)
Apr 21, 2026
3
QUEK David Yong Qi (Reporting)
Apr 21, 2026
3
KOH Pee Keat (Reporting)
Apr 21, 2026
3
TEO Peng Kwang (Reporting)
Apr 21, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Sep 16, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 1, 2025
CORRESP
Form CORRESP - Correspondence
Mar 28, 2025
CORRESP
Form CORRESP - Correspondence
Mar 28, 2025
CORRESP
Form CORRESP - Correspondence
Feb 14, 2025
LETTER
Form UPLOAD - SEC-generated letter
Feb 13, 2025